Palemo Holdings
2778
Spancrete
5277
Renascience
4889
Oncolys BioPharma
4588
Kitagawa Seiki
6327
JP Stock MarketDetailed Quotes
4595 Mizuho Medy
- 1434
- -8-0.55%
20min DelayMarket Closed Jan 22 15:30 JST
27.32BMarket Cap7.24P/E (Static)
1458High1430Low122.80KVolume1446Open1442Pre Close176.54MTurnover191052wk High0.99%Turnover Ratio19.05MShares143052wk Low199.635EPS TTM17.83BFloat Cap2138Historical High7.24P/E (Static)12.43MShs Float180Historical Low198.135EPS LYR1.94%Amplitude80.00Dividend TTM1.73P/B100Lot Size5.58%Div YieldTTM
About Mizuho Medy Company
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
Company Profile
Symbol4595
Company NameMizuho Medy
Founded1977-11-02
MarketTSE Standard
Fiscal Year Ends12-31
Address4 Fujinoki-Machi Saga Prefecture
Zip Code841-0048
Phone0942-85-0303
Websitewww.mizuho-m.co.jp
Company Executives
- Name
- Position
- Salary
- Hiroshi Sasaki
- Director and General Manager of Accounting Department
- --
- Toshio Kanbara
- Director, General Manager of Sales Headquarters and General Manager of Overseas Business Division
- --
- Tadashi Imamura
- Director, Managing Director and General Manager of Development Planning Department
- --
- Kenji Narahara
- Director and General Manager of Development Department
- --
- Kazuhiro Ichimaru
- Director and General Manager of Intellectual Property Department
- --
- Fuminari Karakawa
- Chairman of the Board and President
- --
- Shinichi Akiyama
- Independent Director
- --
- Masaru Sasaki
- Independent Director
- --